Determinants of Treatment Toxicity in Patients with Soft Tissue Sarcomas-Reference-Cited by-同舟云学术

Determinants of Treatment Toxicity in Patients with Soft Tissue Sarcomas

Published:2023-06-26 Issue:8 Volume:75 Page:1638-1645
ISSN:0163-5581
Container-title:Nutrition and Cancer
language:en
Short-container-title:Nutrition and Cancer

Author:

Schönenberger Katja A.¹²^ORCID,Reber Emilie¹^ORCID,Schläppi Karin¹,Baumgartner Annic¹³,Stanga Zeno¹^ORCID,Kollár Attila⁴^ORCID

Affiliation:

1. Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism (UDEM), Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland

2. Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland

3. Division of General Internal and Emergency Medicine, Medical University Department, Kantonsspital Aarau, Aarau, Switzerland

4. Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland

Publisher

Informa UK Limited

Subject

Cancer Research,Nutrition and Dietetics,Oncology,Medicine (miscellaneous)

Link

https://www.tandfonline.com/doi/pdf/10.1080/01635581.2023.2227405

Reference24 articles.

1. Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆

2. Sarcopenia and obesity among patients with soft tissue sarcoma – Association with clinicopathologic characteristics, complications and oncologic outcome: A systematic review and meta-analysis

3. Interactions of lean soft-tissue and chemotherapy toxicities in patients receiving anti-cancer treatments

4. A review of body composition and pharmacokinetics in oncology

5. Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index